Table 2 Frequency distribution of changes in best-corrected visual acuity from baseline to month 6
Change in BCVAEyes, n (%)
Bevacizumab (n  =  14)PDT plus IVTA (n  =  14)
⩾3-Line increase5 (36)3 (21)
0 to <3-Line increase7 (50)4 (29)
<3-Line decrease2 (14)5 (36)
⩾3-Line decrease0 (0)2 (14)

  • BCVA, Best-corrected visual acuity; IVTA, intravitreal triamcinolone; PDT, verteporfin therapy.